ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript December 10, 2024
ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.07.
Operator: Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies Second Quarter Fiscal Year 2025 Earnings Call. We appreciate your time and interest in IPA. Today’s call will be led by our CEO, Dr. Jennifer Bath; and our CFO, Kristin...
